0 1

Cited 0 times in

Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention

Authors
 Sungsoo Cho  ;  Moonki Jung  ;  Jong-Hwa Ahn  ;  Min Gyu Kang  ;  Jae Seok Bae  ;  Jin-Sin Koh  ;  Seok-Jae Hwang  ;  Hwi Seung Kim  ;  Sang-Wook Kim  ;  Jin-Yong Hwang  ;  Young-Hoon Jeong 
Citation
 JACC-CARDIOVASCULAR INTERVENTIONS, Vol.18(6) : 720-733, 2025-03 
Journal Title
JACC-CARDIOVASCULAR INTERVENTIONS
ISSN
 1936-8798 
Issue Date
2025-03
MeSH
Aged ; Biomarkers / blood ; Blood Coagulation* ; Coronary Artery Disease* / blood ; Coronary Artery Disease* / diagnosis ; Coronary Artery Disease* / diagnostic imaging ; Coronary Artery Disease* / mortality ; Coronary Artery Disease* / therapy ; Coronary Thrombosis* / blood ; Coronary Thrombosis* / etiology ; Coronary Thrombosis* / mortality ; Diabetes Mellitus* / blood ; Diabetes Mellitus* / diagnosis ; Diabetes Mellitus* / mortality ; Female ; Fibrinolysis ; Glycated Hemoglobin / metabolism ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention* / adverse effects ; Percutaneous Coronary Intervention* / mortality ; Risk Assessment ; Risk Factors ; Thrombelastography ; Time Factors ; Treatment Outcome
Keywords
cardiovascular event ; clot strength ; coronary artery disease ; diabetes mellitus ; percutaneous coronary intervention
Abstract
Background: A heightened prothrombotic environment, combined with premature and more aggressive atherosclerosis, contributes to the elevated cardiovascular risk in patients with diabetes mellitus (DM).

Objectives: The aim of this study was to evaluate the association between DM status and thrombogenicity and their prognostic implications in patients with significant coronary artery disease.

Methods: A total of 2,501 patients with coronary artery disease undergoing percutaneous coronary intervention, with on-admission glycated hemoglobin and thrombogenicity indexes (measured by thromboelastography). Major adverse cardiovascular events (MACE) were defined as a composite of all-cause death, myocardial infarction, or stroke within 4-year follow-up.

Results: Patients with DM (n = 970 [38.8%]) demonstrated significantly higher platelet-fibrin clot strength (PFCS), as indicated by maximal amplitude (median [Q1-Q3]: 67.1 [62.2-72.2] mm vs. 65.5 [61.0-70.4] mm; P < 0.001), and reduced fibrinolytic activity, measured by lysis at 30 minutes (median [Q1-Q3]: 0.1% [0.0%-1.0%] vs. 0.2% [0.0%-1.3%]; P = 0.003), compared to patients without DM. PFCS level was closely related with diabetic status, showing a positive relationship with glycated hemoglobin level up to 7.0% and then reaching a plateau. In a multivariable analysis, high PFCS phenotype defined as maximal amplitude ≥68 mm (HR: 1.39; 95% CI: 1.07-1.81; P = 0.015) and DM phenotype (HR: 1.38; 95% CI: 1.05-1.79; P = 0.018) were independently associated with MACE occurrence. The presence of diabetic phenotype and high PFCS exhibited an additive effect on MACE occurrence (HR: 2.49; 95% CI: 1.77-3.51; P < 0.001).

Conclusions: In percutaneous coronary intervention-treated patients, diabetic status and clot-strength value were significantly correlated. High clot-strength phenotype increased the risk for MACE, irrespective of diabetic phenotype. (Gyeongsang National University Hospital Registry [GNUH]; NCT04650529).
Full Text
https://www.sciencedirect.com/science/article/pii/S1936879824018181
DOI
10.1016/j.jcin.2024.12.002
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Cho, Sung Soo(조성수)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/205947
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links